On 15 January 2019, Professor Kevin Outterson, executive director of CARB-X, will be featured in a webinar to introduce and explain the public-private partnership CARB-X, which is dedicated to the early development of innovative antibiotics, vaccines, and other products to fight superbugs. Find more information and a registration link here.

On December 13th, 2018, Collaborative Drug Discovery (CDD) will host a webinar on New Strategies in Antibiotic Drug Development with Dr. Arthur “AJ” Campbell & Dr. Cheryl Quinn. The talk is hosted by CDD, in conjunction with Pew Trusts and moderated by Keystone Symposia CSO Dr. Thale Jarvis with an introduction from Dr. Wes Kim, Senior Officer of Pew Trust's Antibiotic Resistance Project. The discussion will be highly informed with a focus on: How we can move the needle

On 11 December, 14:00 GMT, the Leading Health System Network (LHSN), a collaborative network of healthcare leaders and organisations, will host a webinar discussing the OECD report ‘Stemming the Superbug Tide: Just a Few Dollars More’. This report describes the long-term public health and economics consequences of the rise in AMR and identifies effective solutions to tackle this top public health priority. For more information visit the LHSN website.

Stemming the Superbug Tide: Just a Few Dollars More – Looking at the New OECD Report on AMRCommunity manager2019-01-11T15:21:15+00:00

The Uppsala Antibiotic Center launches their newest outreach project, "The AMR Studio", with the occasion of the World Antibiotic Awareness Week 2018. The AMR Studio is a podcast dedicated to highlighting the multidisciplinary research on antimicrobial resistance that is happening around the world. Formatted around interviews with professionals working in all aspects of the topic, they aim to bring the global and trans-sectorial nature of the fight against antimicrobial and antibiotic resistance to anyone with an interest. In

The AMR Studio – A podcast by the Uppsala Antibiotic CenterCommunity manager2019-01-11T15:21:59+00:00

On Friday, Sept. 14, 2018, at 10 a.m. EDT, The Pew Charitable Trusts hosts Dr. Scott Gottlieb, commissioner of the U.S. Food and Drug Administration, as he announces the agency’s plans to combat antibiotic resistance. Following Gottlieb’s remarks, a panel of FDA senior officials will further explore the agency’s new and ongoing activities to support antibiotic innovation and ensure that antimicrobial drugs are used according to good stewardship practices in human medicine and animal agriculture. Click here to

On September 13th, 2018, Collaborative Drug Discovery (CDD) will host a webinar with Christopher Lipinski and Barry Bunin. The discussed topics will include: Going beyond the Rules of 5 New technologies to better assess the quality of screening data Experimental culture and sociology as a factor in clustering of results Plus topics you would not expect, like how scientists can (and should) respond to the growing opioid addiction crisis – which has actually lowered life expectancy in America

A Discussion with Chris Lipinski and Barry BuninCommunity manager2019-01-11T15:22:38+00:00

Webinar on models for drug development programmes by Charles River: The emergence of antibiotic-resistant bacteria and genetic variance amongst viruses has embattled the development of effective treatment and vaccination against infectious diseases, leading to a worldwide crisis in medical care. This webinar will help you choose the correct models for your drug development program; from early in vitro screening assays providing identification of efficacy, to a range of clinically relevant in vivo models. We also explore the use

Battle of the Bugs: Designing the Best Approach in the Fight Against Infectious DiseaseCommunity manager2019-01-11T15:25:40+00:00

On June 26th, 2018, Collaborative Drug Discovery (CDD) hosted a webinar where moderator Ashley Farley, Associate Officer of Knowledge & Research Services at the Bill & Melinda Gates Foundation (BMGF) discussed drug discovery data with Dr. Andrew Leach from ChEMBL and Dr. Evan Bolton from PubChem. The presenters discussed the emergence of freely available PubChem and ChEMBL resources for chemical and biological Structure-Activity-Relationship (SAR) data and their impact on the global drug discovery informatics landscape. The relationship between

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research & Development Partnership (GARDP) aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access.

CONNECT

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read our cookie policy